Altre lingue Co-Diagnostics, Inc.

Azioni

CODX

US1897631057

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 21/06/2024			Variaz. 5gg	Var. 1 gen.
1,47 ^USD	+1,38%		-7,55%	+10,53%

14/06	Co-Diagnostics, Inc. Presenta la prima domanda FDA 510(k) per la piattaforma Co-Dx PCR Pro	CI
13/05	CO-DIAGNOSTICS, INC. : HC Wainwright mantiene la raccomandazione Neutral	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21	18/06
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform	17/06
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform	14/06
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform	14/06
Co Diagnostics : Submits First FDA 510(k) Application for Co Dx PCR Pro Platform Form 8 K	14/06
Co-Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results	09/05
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast	25/04
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan	24/04
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	15/04
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	12/04
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	12/04
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions	04/04
Co-Diagnostics, Inc. Appoints Executive Appointments	04/04
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address	21/03
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England	18/03
Co-Diagnostics, Inc. Appoints Richard Abbott as President	15/03
Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.	14/03
Co-Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results	14/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Co-Diagnostics, Inc.

Azioni

CODX

US1897631057

Altre lingue

Filtri